Skip to main content

Are your handwash,soap,toothpaste a cancer risk to you and your kids?

Can we trust the FDA? Colgate-Palmolive Removed This Potentially Harmful Chemical From Its Soap Products - But It's Still In Your Toothpaste
Since kids have a habbit of swallowing a small part of the toothpaste, it is a serous danger to them.

In 2011, Colgate-Palmolive removed a chemical called triclosan from its soap products, citing "changing consumer preferences." But according to a New York Times article, the change was more likely motivated by concerns raised by consumer groups and Congressional leaders over the potentially harmful effects of the chemical.
While long-term research in humans is lacking, several studies of the effects of triclosan in mice, rats and frogs, found reduced fertilitydevelopment issues in fetuses, and increased cancer risk.
However, triclosan still remains an active ingredient in Colgate Total, the company's number one selling toothpaste. Why is a product that may not be safe for our hands still in a product that goes into our mouths?

The Role of the FDA

A Bloomberg News investigation places some of the blame on the U.S. Food and Drug Administration approval process, highlighting 35 pages of recently released toxicology data from the approval application for Colgate Total. Those pages show that there may have been some red flags about triclosan's safety that the FDA should have examined further.
For instance, the application included a study that found "fetal bone malformations in mice and rats." It is important to recognize that chemicals can affect animals differently than humans, especially because animal testing can involve sky-high doses of the chemical in question. However, often these kinds of findings in animals mean further testing is warranted before the product is approved for humans.
Another issue is that the FDA "relies on company-backed science to show products are safe and effective," according to the Bloomberg story. This means that instead of having independent, third-party researchers determine the effectiveness and safety of a given product, the FDA often accepts research studies funded by the company that is trying to seek approval.
Triclosan is an antimicrobial agent, meaning that it helps to "slow or stop the growth of bacteria, fungi, and mildew," according to the Environmental Protection Agency. It first started to appear in antibacterial hand soap products in the 1970s.
The FDA has never issued a comprehensive ruling on triclosan's effectiveness and safety - even though it originally said it would look into triclosan in 1974. That was two years before "the U.S. Toxic Substances Control Act of 1976, which aimed to comprehensively regulate chemicals, grandfathered in existing substances with no safety testing," Bloomberg notes. Now the FDA says it will issue a ruling on triclosan in 2016.
While companies have an obligation to the safety and health of their customers, they can also have a lot of money riding on the approval of a new product.

The Risks and Benefits of Triclosan

When it comes to consumer safety, the FDA needs to determine whether the benefits of a product outweigh the risks. In the case of toothpaste, clinical trials showed that triclosan helped fight plaque germs found in the mouth, reducing the individual's risk of gingivitis, a common gum disease.
According to the company website, "Colgate Total is clinically proven to work better than other toothpastes to reduce these germs that can cause the gum disease gingivitis." Colgate's website also states that the "safety and effectiveness" of the product is supported by more than 80 scientific studies, involving 19,000 people.
Last year, an independent review of the existing research on triclosan in toothpaste concluded that the chemical "reduced plaque, gingival inflammation and gingival bleeding" but that those reductions "may or may not be clinically important." Triclosan was also associated with a "small reduction" in cavities.
"There do not appear to be any serious safety concerns regarding the use of triclosan... toothpastes in studies up to three years in duration," the reviewers concluded.
Colgate is quick to point out that real-world evidence seems to echo these results.


Popular posts from this blog

What needs to be in content that attracts traffic on social media and elsewhere

In a world where content is king, a large volume of high-quality, shareable content is required to build credibility, brand reputation, and grow your digital presence. However, successful content marketing is not measured in the amount of output you produce, but in how well your audience responds to your output, including how often they share it. After all, the more fans and followers who feel compelled to share your blog piece, Facebook post, infographic, video, image, etc., the more value that content inherently adds to your brand.  So, what makes great content share-worthy? Unfortunately, there’s no defined formula for successful viral marketing, but there are several significant similarities between the most popular pieces of content that compel viewers and readers to click ‘Share’. Want to make your content more share-worthy? Here’s a checklist of things irresistibly shareable content should offer your audience: 1. Industry Relevance
2. A Great Hook
3. Controversy
4. Solutions or …

Can Herbalife 'Afresh' cause insomnia(sleeplessness) and heart problems?

Here is another "great" product from Herbalife. Marketed as an ENERGY drink mix. Few people know it contains Gurana seeds which have no active compound giving artificial energy other than caffeine. Afresh also contains additional caffeine

Ingredients of Herbalife Afresh Energy Drink Mix:
Maltodextrin, Orange Pekoe Extract, Guarana Seed Extract, Acidity Regulator - 330 and Caffeine Powder.

Side effect include insomnia, sleeplessness and heart problems, It is especially harmful for people with High blood pressure.

Highlights from Warren Buffett's annual letter to Berkshire Hathaway shareholders

Warren Buffett's highly anticipated annual letter toBerkshire Hathawayshareholders released on Saturday did not disappoint this year with a little something for all fans of the Oracle of Omaha, from professional value investors to the casual admirers of his wit and wisdom.Most newsworthy in this year's edition, the 87-year old billionairepointed out that Berkshire Hathaway now has a $116 billion war chestto spend on a deal, but that prices were too high for him to spend any of it in a big way last year.Buffettwent on to give avaluable investing lessonthat involved quoting a Rudyard Kipling poem from the 1800s. There are plenty of quips in the letter, including a joke likening a CEO's penchant for dealmaking to the sex drive of teenagers. Here are the highlights below: The tax cut:"Berkshire's gain in net worth during 2017 was $65.3 billion, which increased the per-share book value of both our Class A and Class B stock by 23%...A large portion of our gain did not com…